Measuring benefit
Only carefully designed studies can show whether a candidate vaccine actually reduces infection or disease, and by how much, compared with not receiving it.
VACCINE SCIENCE • PUBLIC HEALTH • EDUCATION
Explore accessible, evidence-informed educational resources about vaccines, HIV prevention, clinical research, community participation and the scientific processes that shape public health knowledge.
THE VARG is an independent educational website for people who want to understand how vaccines are studied, how HIV can be prevented, and how clinical research protects the people who take part in it. We write for curious readers, students, community members, caregivers and anyone who wants clearer explanations than headlines usually provide.
Each page focuses on one subject and explains it from first principles: what the key terms mean, what the evidence shows, where real uncertainty remains, and which questions are best taken to a qualified health professional. We do not run studies, provide care or promote products. Our only aim is to make reliable scientific knowledge easier to read and harder to misunderstand.
Learn more about this educational website and the editorial standards we follow.
A vaccine introduces a harmless version, part or blueprint of a pathogen so the immune system can learn to recognize it before a real infection occurs.
The strength and duration of this protection differ from one vaccine to another and from one person to another. Some vaccines prevent most infections; others mainly reduce the risk of severe illness; some need booster doses because protection wanes. Our Vaccine Education guide walks through immune memory, vaccine platforms and how safety is monitored after approval.
Only carefully designed studies can show whether a candidate vaccine actually reduces infection or disease, and by how much, compared with not receiving it.
Every medical product can have side effects. Research identifies common reactions early and continues watching for rare events long after a vaccine is in use.
Trials that do not show protection are still valuable. They tell scientists which strategies to abandon and which immune responses may matter most.
HIV (human immunodeficiency virus) is passed on only through specific body fluids, not through everyday contact. Although no vaccine is yet available, people today can choose from several effective ways to prevent HIV, and they can combine them.
Read the HIV Prevention guide for clear explanations of testing, PrEP, PEP, condoms and why effective treatment prevents sexual transmission.
Decades of work have produced important scientific insights but no approved vaccine. HIV mutates rapidly, exists as many genetically diverse strains and hides inside the immune cells it infects.
The virus changes so quickly that an immune response trained on one strain may miss another circulating in the same community.
Researchers are studying rare antibodies that can block many HIV strains, and testing whether vaccines can guide the body to make them.
Current candidates are in early-phase trials that measure safety and immune responses. None has shown proven protection.
Explore HIV Vaccine ResearchClinical trials test medical interventions in people, step by step, with independent oversight at each stage. Taking part in research is different from receiving established treatment: the purpose is to generate knowledge, and the outcome for any individual participant is uncertain.
Clinical Trial Education explains phases, randomization, placebo controls and the rights every participant keeps.
Small groups; focus on safety, dosing and initial immune response.
Larger groups; more safety data and refinement of dose and schedule.
Thousands of participants; tests whether the intervention works and identifies less common side effects.
Regulators evaluate the full evidence; monitoring continues after approval.
Modern research ethics grew out of painful historical failures. Today, widely recognized frameworks set out core principles that ethics committees apply before and during every study involving people.
Voluntary, informed consent and the freedom to withdraw at any time.
Minimizing possible harms and ensuring risks are reasonable relative to potential benefits.
Fair distribution of the burdens and benefits of research across groups.
Ethics committees approve and oversee studies before and while they run.
Read about Research Ethics, including privacy protections, fair participant selection and the historical lessons that shaped today’s safeguards.
Communities most affected by a health problem understand its realities in ways researchers may not. Meaningful engagement means involving community members early, explaining research honestly, listening to concerns and reporting results back—whether or not the results are positive.
In HIV prevention research, internationally recognized Good Participatory Practice guidance describes how trial teams and communities can build that relationship. Explore Community Engagement to learn how community advisory boards and transparent communication support trust.
Public health literacy is the ability to find, understand and evaluate health information well enough to make informed decisions. A useful starting point is recognizing the strength of the evidence behind a claim.
Conclusions supported by many independent, high-quality studies and endorsed by major scientific bodies.
Promising results from a limited number of studies that still need confirmation.
Early laboratory, animal or small human studies that cannot yet support practical conclusions.
Assertions without credible evidence, or that contradict well-established findings.
Public Health Literacy offers practical tools for reading statistics, judging sources and recognizing misinformation.
Immune memory, vaccine platforms, development stages and safety monitoring.
Read the guideTesting, PrEP, PEP, condoms and U=U, explained without stigma.
Read the guideWhy HIV is difficult to vaccinate against and what scientists are testing now.
Read the guidePhases, informed consent, participant rights and how results are interpreted.
Read the guideThe principles and review systems that protect people who take part in research.
Read the guideAdvisory boards, participatory principles and rebuilding trust in research.
Read the guideNo. THE VARG is an independent educational information website. It does not provide medical care, run clinical trials, recruit research participants or represent any government health authority, university or vaccine manufacturer.
No HIV vaccine has been approved by regulators for general use. Several candidates are being studied in early-phase clinical trials, and earlier large efficacy trials did not show enough protection to proceed. Our HIV Vaccine Research page explains where the science stands and why it is so challenging.
No. The content explains concepts in general terms. Decisions about vaccination, HIV testing, prevention options or treatment should be made with a qualified healthcare professional who knows your circumstances.
Time-sensitive medical statements are checked against published guidance from recognized public health agencies and peer-reviewed research, and the sources are named on each page. When guidance changes, pages are updated. You can report a possible error through the Contact Us page.
No. To keep the reading experience focused and self-contained, THE VARG does not use outbound hyperlinks. Where we rely on an outside source, we name the organization, document title and publication date as plain text so you can look it up independently.
Start with Vaccine Education for the fundamentals of immunity and vaccine development, then follow the guided pathway on the Learning Resources page.
Follow a structured pathway from vaccine fundamentals to HIV vaccine science, clinical trials, ethics and community engagement.